New AMP Report Analyzes Costs, Value of Genomic Sequencing

 Email not displaying correctly?
View it in your browser.
  Lab and Pathology Insider Logo  
  April 19, 2016  
placeholder ENFORCEMENT
CMS Scrutiny Continues for Theranos
By Ron Shinkman, Editor, Laboratory Industry Report
The Theranos saga has just entered its most critical state, as the Centers for Medicare & Medicaid Services (CMS) recommended the company's CLIA certification be revoked for…
Read More
placeholder FUNDING
At-Home Testing Company Cor Crowdfunding for Commercialization
By Lori Solomon, Editor, Diagnostic Testing & Emerging Technologies
At-home testing company Cor (San Francisco) has taken to online crowdfunding to commercialize its blood chemistry device. As of April 6, the company had pledges on…
Read More
placeholder NEXT-GENERATION SEQUENCING
New AMP Report Analyzes Costs, Value of Genomic Sequencing
By Stephanie Murg, Managing Director, G2 Intelligence
At a time when data on cost and clinical outcomes are in high demand yet short supply, the Association for Molecular Pathology (AMP, Bethesda, Md.) is taking an…
Read More
placeholder GENETIC TESTING
TAPUR Study Launches to Evaluate Off-Label Uses of Targeted Cancer Therapies
By Lori Solomon, Editor, Diagnostic Testing & Emerging Technologies
The Targeted Agent and Profiling Utilization Registry (TAPUR) study began recruiting its first patients last month. The trial, the first clinical trial undertaken by …
Read More
Follow on Twitter |  Forward to a Friend

For questions concerning delivery of this email, please contact customer service at:
(888) 729-2315 | customerservice@plainlanguagemedia.com

Copyright © 2016, All rights reserved.
Plain Language Media LLLP
PO Box 509, New London, CT 06320